Cost-effectiveness analysis for the Belgian health care setting of drug X in second line treatment of advanced renal cell carcinoma / Chantal van Gils

Cost-effectiveness analysis for the Belgian health care setting of drug X in second line treatment of advanced renal cell carcinoma / Chantal van Gils